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Abstract
A key feature of the vertebrate adaptive immune system is acquired immune
memory, whereby hosts launch a faster and heightened response when chal-
lenged by previously encountered pathogens, preventing full infection. Here, we
use a mathematical model to explore the role of ecological and epidemiological
processes in shaping selection for costly acquired immune memory. Applying
the framework of adaptive dynamics to the classic SIR (Susceptible-Infected-
Recovered) epidemiological model, we focus on the conditions that may lead
hosts to evolve high levels of immunity. Linking our work to previous theory,
we show how investment in immune memory may be greatest at long or inter-
mediate host lifespans depending on whether immunity is long lasting. High
initial costs to gain immunity are also found to be essential for a highly effec-
tive immune memory. We also find that high disease infectivity and sterility,
but intermediate virulence and immune period, increase selection for immu-
nity. Diversity in host populations through evolutionary branching is found to
be possible but only for a limited range of parameter space. Our model suggests
that specific ecological and epidemiological conditions have to be met for
acquired immune memory to evolve.
Introduction
An adaptive immune system appears to exist in almost all
vertebrates (Cooper and Alder 2006). A key feature of this
defense mechanism is acquired immune memory,
whereby hosts can protect themselves from subsequent
infections from the same pathogen. This mechanism is
incorporated in to the classic Susceptible-Infected-Recov-
ered (SIR) epidemiological model through the assumption
that upon recovery from infection, hosts gain long-lasting
immunity to disease such that they cannot be re-infected
(Kermack and McKendrick 1927; Anderson and May
1979). This adaptive immune response is perhaps the
most advanced defense mechanism possessed by verte-
brate hosts to natural parasites and pathogens. However,
the factors that may impact on the evolution of such an
immune memory from a theoretical perspective are still
not fully understood.
Clearly, selection for any form of defense to parasitism
is governed by the ecological and epidemiological envi-
ronment of the host. A common prediction is that invest-
ment in defense should be monotonic with host lifespan
(Medzhitov and Janeway 1997; Rinkevich 1999), but in a
key theoretical study Miller et al. (2007) showed that this
is not always the case. In particular, they found that if
hosts could evolve the length of the immune period then
investment was indeed greatest for long-lived hosts, but if
permanent acquired immunity was evolved then invest-
ment was instead greatest at intermediate lifespans (Miller
et al. 2007; see also van Boven and Weissing, 2004).
Understanding the differing ecological feedbacks between
these two models is therefore crucial to understanding the
evolution of immunity in different host populations. Fur-
ther to this work, van Baalen (1998) found that an effec-
tive clearance mechanism, crucial to the development of
immune memory, was most likely against parasites with
intermediate virulence, while Boots and Bowers (1999)
showed that coexistence of types with high and low clear-
ance levels was possible. Boots and Bowers (2004) further
investigated the evolution of immune period, and found
very similar results – long-lasting immunity was most
likely against parasites with intermediate virulence and
coexistence of types with short- and long-lasting immu-
nity was possible. Recent theoretical work has also studied
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the evolutionary ecology of the maternal transfer of
immunity (Garnier et al. 2012) and of immune priming
in invertebrates (Best et al. 2013), yet there is still a clear
need for a thorough investigation of the evolution of
immune memory in vertebrate hosts.
The vertebrate adaptive immune system involves a
complex set of genetic and molecular processes (Bonilla
and Oettgen 2010). T and B lymphocytes, the main
effector cells of the adaptive immune system, are acti-
vated to fight infection and produce long-lasting mem-
ory cells that are able to recognize specific antigenic
configurations of previous pathogens. This immune
memory then allows a faster immune response on
subsequent challenges and the effective prevention of
future infections. There is currently much interest in
how the adaptive immune response first evolved in ver-
tebrates from an immunological perspective (Cooper and
Alder 2006; Litman et al. 2010; Hirano et al. 2011). The
principle genes of the adaptive immune system have
been identified in every jawed vertebrate that has been
tested (Cooper and Alder 2006), suggesting that, while it
has continued to be fine-tuned over subsequent evolu-
tionary time, the adaptive immune system was probably
first formed in the earliest vertebrates (Cooper and Alder
2006). Moreover, the differing structures of the adaptive
immune system in jawed and jawless vertebrates suggests
that these two groups have experienced different
selection pressures for the development of the adaptive
immune system (Cooper and Alder 2006; Litman et al.
2010). Furthermore, there is increasing evidence that
both invertebrates (Little and Kraaijeveld 2004; Schmid-
Hempel 2005) and plants (Spoel and Dong 2012) also
have some form of specific, long-lasting immunity to
infections. Given the seemingly universal prevalence of
an adaptive immune system in vertebrate populations,
there is clearly now little genetic variation in immune
memory. However, there are still important insights to
be gained for our understanding of how the ecological
and epidemiological environment of hosts and parasites
may have initially shaped selection for immune memory,
of the apparent discrepancy in investment in immunity
with host lifespan (Miller et al. 2007) and of the
fundamental differences between populations with (SIR-
type models) and without (Susceptible-Infected-Suscepti-
ble [SIS]-type models) immune memory.
Our focus here is to investigate the ecological and
epidemiological conditions that would promote the evo-
lution of an acquired immune memory in host popula-
tions. In developing such a theoretical model, there are
a number of key assumptions we must decide upon.
For example, is immunity perfect or imperfect (i.e., can
immune individuals still become infected but at a
reduced rate)? Furthermore, is immunity permanent or
can it wane over time? There is also a subtle distinction
in how we interpret the transition to immunity. We
shall assume that some proportion of recovering hosts
become immune, but is it predetermined that some
hosts have a fully functioning immune system and
others none, or do all hosts have an equal probability
of becoming immune? This distinction is particularly
important from an evolutionary perspective because it
impacts on how the life-history costs of investing in
immunity are incurred. If only certain hosts will ever
become immune only those hosts should pay the costs,
whereas if all hosts have the potential to become
immune all hosts will pay a cost. Each of these assump-
tions is likely to play some role in determining the out-
come of evolution. Here, as a first step, and to allow
comparison with the work of Miller et al. (2007), we
shall assume that immunity is perfect but that it can
wane (while Miller et al. [2007]; Model III) assumed
immunity was perfect and permanent). We shall also
assume that all hosts have the potential to become
immune. As such, increased investment in immunity
corresponds to a “stronger” immune system and a
greater probability of becoming immune upon recovery.
We shall also assume that there is a single host and sin-
gle pathogen population, allowing us to focus more on
the role of epidemiological feedbacks to evolution, but
implicitly removing the role of specificity, a further key
feature of the adaptive immune system (see Discussion).
Modelling
Given the assumptions outlined in the Introduction, we
model the population dynamics of Susceptible, Infected
and Recovered (immune) hosts with the following set of
ordinary differential equations (c.f. Miller et al. 2007),
dS
dt
¼ ða qNÞðSþ f1I þ RÞ  bS bSI þ cð1 lÞI þ dR
(1)
dI
dt
¼ bSI  ðbþ aþ cÞI (2)
dR
dt
¼ clI  ðbþ dÞR (3)
The ecological and epidemiological processes of the
model are also presented graphically in Figure 1 with a
schematic of the model. All hosts are born susceptible
at rate a (which is reduced through density dependence
by q) but infected hosts may have reduced fecundity by
a factor f1. We shall assume that immune hosts repro-
duce at the same rate as susceptible hosts throughout
this article. All hosts die at natural mortality rate b.
Transmission of disease is a mass-action process
between susceptible and infected hosts with coefficient
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b. Infected hosts suffer increased mortality (defined as
virulence) a and may recover from infection at rate c.
Upon recovery, a proportion, l of hosts become
immune, while the remainder do not gain immunity
and return to susceptibility. As stated in the Introduc-
tion, we will assume that immunity is perfect, such that
immune hosts have no risk of infection. However, we
do assume that immunity can be lost at rate c. Analysis
of these population dynamics shows that this model
yields straightforward SIR-type behavior, with a forward
bifurcation at R0 ¼ bS^=ðbþ aþ cÞ ¼ 1 (where S^ is the
disease-free equilibrium) with one unique endemic equi-
librium for R0 > 1. We note that the key differences
between our model and model III of Miller et al.
(2007) are that we allow immunity to wane and that
we allow infected hosts to be sterilized.
We shall consider the evolution of becoming immune
by allowing the parameter l to evolve in the population.
Following the standard methods of host evolutionary
studies, we will assume that the cost of investment in
defense, specifically immunity, is to the birth rate of the
host, a. Note that all hosts pay this cost, not just those
that are in the R class. Our focus is on how immunity
may initially evolve in a host population and how strong
the resulting immune memory will be, or, in other words,
how populations may move from an SIS framework (i.e.,
recovery but not immunity) toward an SIR framework. It
is likely that any initial investment in immunity would be
particularly costly to create the necessary genetic and
physiological structures for immune memory. We shall
therefore assume that the trade-off curve is initially steep,
with a small increase in immunity causing a large drop in
reproduction, with costs decelerating at higher levels of
immunity. Noting that l must fall within the interval
[0,1], we can express this trade-off as,
a ¼ aðlÞ ¼ amin þ ðamax  aminÞ 1 l
1þ kl (4)
where the parameter k controls the curvature of the
trade-off. This produces a smooth, decreasing curve
between extreme ends of the trade-off (lmax) and (lmin,
amax). We take k > 0 or the shape we require, which we
refer to as “decelerating” in terms of costs, and consider
its “strength” to mean how strongly curved the trade-off
is (i.e., how steep the initial decline in reproduction).
As we are concerned with how the epidemiological pro-
cesses feedback to the selection pressure for immunity, we
will use the evolutionary framework of adaptive dynamics
(Geritz et al. 1998). As such, we assume that a resident
strain at equilibrium, with traits (lr, ar), is invaded by a
rare mutant whose trait values differ slightly from the resi-
dent (lm, am). The success of the mutant is governed by its
invasion fitness, defined as its growth rate when rare. We
use the Next Generation Matrix approach (Hurford et al.
2010) to calculate the fitness. We decompose the Jacobian
of the mutant dynamics in to the form J = FV where,
F¼
am  qN f1ðam  qNÞ þ cð1 lmÞ am  qN þ d
0 0 0
0 0 0
0
@
1
A
(5)
is a matrix containing terms relating to the creation of
susceptible hosts from each host class, and,
V ¼
bþ bIr 0 0
bIr bþ aþ c 0
0 clm bþ d
0
@
1
A (6)
is a matrix containing terms involving the transition of indi-
viduals between classes and the death of hosts. Note that we
have counted recovering infecteds, who are not immune and
hosts who have lost their immunity as creation of susceptible
host terms in the matrix F for analytical ease, but these
matrices still conform to the conditions for using the next
generation matrix (Hurford et al. 2010). The fitness of a
mutant host is then q(FV1)1 where q denotes the spectral
radius of the matrix. This produces a fitness as shown below,
S ¼ am  qNr
bþ bIr þ
ðfIðam  qNrÞ þ cð1 lmÞÞbIr
ðbþ bIrÞðbþ aþ cÞ
þ ðam  qNr þ dÞbIrclmðbþ bIrÞðbþ aþ cÞðbþ dÞ  1
(7)
This fitness decomposes in to the (relative) contribu-
tion to the susceptible pool from each host compartment
(S, I and R) weighted by the probability of hosts entering
Figure 1. A schematic of our epidemiological model. The
demographic processes of births and deaths are shown with gray
lines, and the epidemiological processes of transmission, recovery,
virulence, and waning immunity with black lines. The key “event” in
our model is marked by the dot, where recovering hosts will either
gain immunity and move to the recovered class, or will gain no
immunity and return to the susceptible class.
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each compartment and the time spent in each
compartment.
Results
When will the host invest in any immunity?
We first consider when a host population with no immu-
nity will begin to invest in immune memory. As such we
assume that initially l = 0 (the system is SIS). The selec-
tion gradient at this point reduces as shown below,
@s
@lm

lm¼lr¼0
¼ a
0ð0Þ
bþ bIr þ
ðfIa0ð0Þ  cÞbIr
ðbþ bIrÞðbþ aþ cÞ
þ ðamax  qNr þ dÞbIrcðbþ bIrÞðbþ aþ cÞðbþ dÞ (8)
Note that R = 0 ⇒ N = S + 1. This clearly comprises
two negative terms, associated with the marginal loss of
reproduction as a cost (as well as the loss of hosts recov-
ering to susceptibility) a′(l) < 0, and a positive term
associated with the marginal gain of increased reproduc-
tion from immune hosts. For hosts to evolve an immune
memory, it is necessary that the above expression yields
½@s=@lmlm¼lr¼0[0 (i.e., there is a positive selection gra-
dient at l = 0. Noting that, a′(0) = (amax  amin)
(1 + k) and that (b + a + c)/b = Sr the equilibrium sus-
ceptible density, this expression can be arranged to give
the following:
k\
cðamax  qNr  bÞ
ðamax  aminÞðSr=Ir þ fIÞðbþ dÞ  1 (9)
The bigger the right-hand-side of equation (9), the
greater range of trade-offs there are where the host will
evolve an immune system; that is, the range incorporates
“stronger” decelerating trade-offs, with steeper initial
declines in reproduction. There will always be an upper
limit on k for immunity to evolve, as for initially very
steep trade-offs the cost of gaining immunity (going from
l = 0 to l > 0) will be too high. It is clear that most of
the model parameters therefore influence the potential for
immunity to evolve, both directly and through the term
Sr/Ir. The shaded contour-plots in Figure 2 further
explore this result, showing how the range of trade-offs
for which immunity is evolved (i.e., for which equa-
tion [9] is satisfied) varies, from no decelerating trade-
offs (k < 0; white) to strongly decelerating trade-offs
k < 5 + ; black). In particular it can be seen that invest-
ment occurs for stronger trade-offs where hosts are long-
lived (2A; small b) and immunity is long lasting (2A;
small d). This is to be expected as hosts with high death
rates are unlikely to survive long enough to benefit from
immunity, while if immunity is lost too rapidly its benefit
is extremely limited. We also see that investment in
immunity requires the parasite to be highly sterilizing
(2B; small fI), but, generally, avirulent (2B; small a). High
sterility causes a large fitness loss to hosts, increasing the
selection for immunity. However, if virulence (that is,
parasite-induced mortality) is too large, hosts are unlikely
to recover from disease and therefore are unlikely to ever
become immune.
How much immunity will the host evolve?
Epidemiological and ecological parameters
Having considered when immunity is likely to evolve at
all, our focus turns to how much immunity the host will
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Figure 2. The range of trade-off curvatures for which equation (9) is
satisfied, resulting in initial investment in immune memory. (A)
Varying death rate, b, and waning immunity, d, (B) varying virulence,
a, and sterility, f1. Shading varies from white for k < 0 to black for
k < 5 or more, with contours shown for greater clarity. Default
values: b = 0.5, a = 0.5, c = 0.5, q = 0.1, b = 2, d = 0.1, f1 = 0.1,
amax = 5, amin = 1.
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evolve. In other words here, how likely will it be that a
recovering host becomes immune? A singular strategy of
the system, a (potentially temporary) “stopping point” of
evolution, occurs when the selection gradient is zero and
there is no longer any directional selection (recall that
l ∊ [0, 1]. This can be expressed to give a condition in
terms of the trade-off,
@s
@lm

lm¼lr
¼ 0 ) a0ðlÞ ¼  cðaðlÞ  qNr  bÞðbþ dÞðSr=Ir þ fIÞ þ cl
(10)
The stability of this singular point depends on two
second-order terms. The strategy is evolutionarily stable
provided ½@2s=@l2mlm¼lr\ 0, meaning that it is locally
uninvadible. The strategy is convergence stable provided
½@2s=@l2m þ @2s=@lm@llm¼lr\0, meaning that it is
locally attracting.
We are initially focussing on the stable level of immu-
nity hosts should invest in, and we therefore look for
CSSs (continuously stable strategies) – singular strategies
that are both evolutionarily stable and convergence stable
and therefore long-term attractors of evolution (Eshel
1983; Christiansen 1991; Geritz et al. 1998). We therefore
choose a gently decelerating trade-off curvature, k = 2,
that guarantees a CSS for the majority of parameter
values tested. We shall consider the importance of the
trade-off shape further in the next section. We again pres-
ent our results using shaded contour-plots in Figure 3,
this time showing the level of immunity invested in.
White regions indicate no immunity (l = 0) with darker
shadings indicating a greater level of immunity.
Investment is greatest (darker colors) at intermediate
or high host lifespans depending on the length of immu-
nity (vertical axis, 3A). Short-lived hosts with high death
rates are never likely to live long enough to benefit signif-
icantly from immunity so investment is always minimal.
However, very long-lived hosts may only need to invest a
small amount to ensure that they shall become immune
at some point in their lives. This effect is amplified as the
immune period 1/(b + d) increases, as a low level of
investment by long-lived hosts ensures they will be
immune for a significant proportion of their life. We thus
confirm the result from Miller et al. (2007) here, that
investment is greatest at intermediate lifespans when
immunity is permanent, as it is more important for these
hosts to become immune earlier in their life. For interme-
diate- and short-lived hosts, investment is at its highest at
low rates of waning immunity (horizontal, 3A) as would
be expected. Interestingly, however, in long-lived hosts
investment is in fact greatest at intermediate rates of wan-
ing immunity. We explore this result further in Figure 3D.
The dashed line shows the purely epidemiological effects of
increasing d on the density of immune hosts where l does
not evolve (we fix l be the CSS value at d = 0), while the
solid line shows the effect when l does evolve to its CSS.
Increasing waning immunity naturally acts to reduce the
density of immune hosts. However, by increasing invest-
ment hosts are able to keep the density of immune hosts
higher, leading to a greater contribution to fitness.
We see clearly that highly sterilizing parasites are
needed for hosts to invest in immunity (horizontal, 3B),
as otherwise the loss to fitness during infection is not sig-
nificant enough to justify the investment. However,
immunity is greatest at intermediate virulence rates (verti-
cal, 3B). Again, we explore this in terms of the impact on
the density of immune hosts where l does not evolve
(dashed line l is fixed at the CSS value at a = 0) and
where it does (solid line) in plot 3E. This shows that
increasing virulence naturally acts to decrease the density
of immune hosts. Again, though, by increasing investment
in immunity this density can be kept at a higher level.
However, for greater rates of virulence, hosts are killed
quickly by disease and they are unlikely to recover and
experience the benefits of immunity, so investment is
dropped. Investment in immunity is clearly greatest against
fast-transmitting parasites (vertical, 3C) as here disease
prevalence will be highest. Investment is highest at interme-
diate rates of clearance (horizontal, 3C). If recovery is low
hosts are unlikely to become immune and so investment
is minimized, but if recovery is high hosts are unlikely to
stay infected for long and, similar to that of virulence, the
loss to fitness through sterility is not as great.
Overall, we see that there are large areas of parameter
space where there is zero investment, and in fact we rarely
see investment of l > 0.5 for the gently decelerating
trade-off shape studied. In general, evolution of a signifi-
cant level of acquired immunity requires (i) intermediate
or long host lifespans; (ii) high infectivity; (iii) intermedi-
ate virulence, and; (iv) high sterility.
How much immunity will the host evolve?
The trade-off
The strength of the trade-off also has a significant effect,
not only on the level of investment but on the nature of the
evolutionary outcome. Figure 4 shows, as one example, the
effect of increasing the trade-off curvature on evolution. As
the trade-off moves from linear (k = 0) to gently decelerating,
the CSS dips slightly before increasing at intermediate val-
ues of k. The singular point then switches from being a CSS
to a branching point. As the strength of the trade-off is
increased further, the branching point moves beyond the
maximum of l = 1 and in this small region the population
will remain monomorphic at maximum investment. There
is then a discontinuity, and for very strongly decelerating
ª 2013 The Authors. Ecology and Evolution published by John Wiley & Sons Ltd. 2227
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trade-offs, the new singular point is a repeller, whereby the
population will remain monomorphic but will move to
minimum or maximum investment depending on the ini-
tial strategy.
Evolutionary branching provides one way in which full
immunity can be achieved (in part of the population, at
least). Here, hosts may approach a singular point that is
convergence stable but evolutionarily unstable, causing
hosts to undergo disruptive selection and branch in to
two distinct strains. Subsequently the two strategies
diverge and, in this scenario, evolve to extreme points,
one with no immunity (l = 0) and one with full immu-
nity (l = 1). An obvious question therefore is how these
two strains compete against each other. Figure 5 shows
simulation output for scenarios where evolutionary
branching occurs. In the first simulation (5A), l evolves
to an intermediate (but low) value before branching – the
subsequent strains diverge to achieve a fully immune
sub-population (l = 1) and a fully susceptible sub-popu-
lation (l = 0). The immune population exists at a lower
density due to the high cost in birth rate they incur (as
evidenced by the darker shading for that strain). How-
ever, in the second simulation (5B), where the parasite is
more virulent and the hosts have a longer lifespan,
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Figure 4. Location of the singular point and its stability for varying
trade-off coefficient k. The solid line denotes a continuously stable
strategies (CSSs) (long-term attractor), the dotted line a branching
point and the dashed line a repeller. Default parameter values as of
Figure 1, but with d = 0.05 and b = 2.5.
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branching takes place at a much higher value of l; here it
is the immune branch that exists at the higher density as
hosts gain a much higher benefit from immunity, even
with the associated costs to reproduction. Here (5B),
hosts who develop immunity dominate the population
whereas those with no immunity only exist at very low
levels.
To investigate the impact of the trade-off shape, in
particular considering the probability of branching occur-
ring, we again use shaded contour-plots to not only find
the location of the singular point in Figure 6, but also to
focus on the stability of the point. Note that we shall
always assume that the population begins from a point of
(l = 0), meaning intermediate repellers will always result
in no investment in immunity. First, we plot waning
immunity (d) against trade-off curvature (d) in Figure 6A
and B. The level of gray shading represents the level of
immunity gained (white = none, l = 0; black = full,
l = 1) and the dotted section represents evolutionary
branching. In the first plot (6A), with intermediate
parasite virulence and host lifespan, branching is more
likely with low rates of waning immunity, which is
expected as if immunity was short-lived then immune
hosts would gain little benefit. With high parasite viru-
lence and long-lived hosts (6B), branching again is more
likely with low rates of waning immunity, however, this
time much stronger decelerating trade-offs are needed for
this to occur. In addition, this creates a large region
selecting for full immunity (l = 1) for very strong decel-
erating trade-offs. This is to be expected when the
strength of the trade-off curvature is very high, whereby
increasing l from low values is very expensive (in terms
of lower reproduction), whereas at higher values increas-
ing l further comes at little cost; hence for very strong
trade-offs, hosts are more likely to become fully immune
or have no immunity than to gain an intermediate level.
(In other words, if they can accept the very high initial
cost of evolving immunity, then much smaller subsequent
costs should be easy to accept.)
We present similar plots for host lifespan (b) against k,
and transmission (b) against k in plots 6C and D. When
considering host lifespan (6C), branching is more likely
for stronger trade-offs with hosts possessing an intermedi-
ate to long lifespan. When considering transmission (6D)
branching is most likely for an intermediate level of
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transmission, however, only when the trade-off strength is
very low; stronger trade-offs result in no investment in
immunity. Interestingly, these plots again highlight that
full immunity can evolve in the population when lifespan
is intermediate to long and transmission is high. In par-
ticular very weak, and even linear, trade-offs can lead to
full immunity when transmission of the pathogen is high
(6D).
Discussion
An acquired immune memory formed by memory T- and
B-cells is common across vertebrate populations and there
is widespread interest in how this immune response has
evolved (Cooper and Alder 2006; Litman et al. 2010;
Hirano et al. 2011). We have studied a mathematical
model to consider the ecological and epidemiological con-
ditions that would favor the evolution of costly acquired
immunity in host populations. Interestingly, our model
has suggested that evolving a fully functioning, highly
effective immune response is only likely in specific cir-
cumstances. A key requirement for high levels of immu-
nity to evolve is that the costs to investing must be
initially rather steep. There is experimental evidence that
immune responses cause costs elsewhere in hosts’ life-his-
tories (e.g., Moret and Schmid-Hempel 2000), and
although clarifying the precise shape of these cost struc-
tures is difficult, we would intuitively expect that any ini-
tial investment in the required genetic and molecular
mechanisms would be particularly costly. Furthermore,
hosts must have intermediate or long lifespans for high
levels of immunity to evolve. Host lifespans will clearly
vary significantly across different species, but we would
certainly expect vertebrates to be relatively long-lived
compared to invertebrates and plants, where the same
form of acquired immunity has not evolved.
It has previously been considered as something of a
paradigm that investment in any form of defense should
be greatest for long-lived hosts (e.g., Medzhitov and
Janeway 1997; Rinkevich 1999). However, in previous
theoretical work Miller et al. (2007) found that this was
not always the case: if hosts evolved the length of the
immune period this result was indeed found to hold, but
if hosts could evolve permanent acquired immunity they
found that investment was instead highest at intermediate
lifespans. Here, we have confirmed and extended the
results of Miller et al. (2007), showing that whenever
immunity is long lasting, not just permanent, investment
in immune memory is greatest at intermediate host life-
spans. This is because long-lived hosts need only invest a
small amount in immunity to ensure that they are
immune for a significant proportion of their lives, but
hosts with intermediate lifespans must ensure immunity
is achieved early on. However, once immunity wanes at a
reasonable rate, this effect weakens and long-lived hosts
invest more in immune memory. We therefore highlight
that it is the length of the immune period that controls
how investment in immune memory varies with lifespan.
More widely, we have found a number of interesting
patterns for increased selection for immunity with epide-
miological parameters. As may be expected, we have
found that high infectivity and disease-induced sterility
increase selection for immunity. Perhaps less intuitively,
though, we have found that intermediate virulence (dis-
ease-induced mortality) selects for higher immunity, as
the relative contribution of immune hosts to fitness can
be kept higher. This result mirrors previous work on the
evolution of clearance (van Baalen 1998) and immune
period (Boots and Bowers 2004), suggesting that this is a
consistent result for the evolution of immunity. For simi-
lar reasons, investment in immunity may also be highest
where that immunity is not permanent; a similarly unin-
tuitive result. Where these conditions are not met, we
generally predict intermediate levels of defense, and often
we find that no immunity at all is selected for. It there-
fore seems that hosts are only predicted to evolve
acquired immunity when faced with pathogens or para-
sites with specific epidemiological features.
A further way in which full immunity can evolve, in
at least part of the population, is through evolutionary
branching. In this case, the population initially evolves
to an intermediate level of immunity, but then branches
in to two distinct sub-populations, one of which then
evolves to no immunity (but high reproduction) and
the other to full immunity (but low reproduction).
Which strain is more prevalent thereafter was found to
depend on the epidemiological and ecological condi-
tions. However, we have found that branching occurs
for only a small range of trade-off shapes with interme-
diate initial costs. All vertebrates tested have been found
to possess the basic foundations of an adaptive immune
system (Cooper and Alder 2006), suggesting that broad
branching events have either not occurred or that the
nonimmune strain has died out. However, we may
speculate that such potential for coexistence in levels of
immune memory may have implications for our under-
standing of the differing adaptive immune systems of
jawed and jawless vertebrates, as well as invertebrates
and plants.
Our focus here has been on understanding how the
epidemiological and ecological environment of hosts
affects selection for adaptive immunity. As such we have
used a relatively simple one host-one pathogen model
to allow for detailed investigation of the dynamics. Of
course, as well as immune memory, a key feature of the
adaptive immune system is specificity: its ability to
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recognize not just one but a wide range of antigenic
configurations. This specificity is likely to have impor-
tant consequences for the evolution of adaptive immu-
nity. In particular, if the development of an adaptive
immune system gives an increased ability to prevent
future infections from multiple pathogens, we may
expect it to be much more likely to evolve. However,
epidemiological models incorporating multiple pathogen
strains have shown the potential for remarkably complex
dynamics (Castillo-Chavez et al. 1989; Gupta et al. 1994;
Andreasen et al. 1997), and a full evolutionary analysis
should be carried out to confirm this intuition. The
pathogen itself will also have a considerable role to play
in the evolution of immunity. For example, it has been
shown that a shorter duration of immune memory can
benefit the host by regulating competition between path-
ogen strains (Wodarz 2003), and that pathogen diversity
may impact the diversity of memory cells reserved by
the host (Graw et al. 2010). In addition, pathogen
coevolution will play a key role in the levels of immu-
nity selected for. These interactions between host and
pathogen(s) will be crucial in how immunity has
evolved and further theoretical analysis of these ques-
tions is necessary to gain greater insights.
Vertebrate hosts exist in a somewhat more complex
environment than the standard SIR framework assumes,
and factors such as competing species, age-structure and
spatial-structure may well have considerable impacts on
our results. For example, Bansal and Meyers (2012) con-
sidered the impact immunity has in an SIR model on a
network, suggesting that higher pathogen virulence may
evolve in the spatial model when hosts acquire immunity
as they must be more infectious to infect populations
multiple times. There are also an array of genetic and
molecular components to the development of an adaptive
immune system, all of which we have combined together
in to one term for immunity. Within-host processes will
play a crucial role not just in fighting infection but also
in the selection pressures for the development of an
immune memory, and combining such processes with
our evolutionary ecology approach may reveal further
important insights.
Recent years have seen considerable progress in our
immunological understanding of the adaptive immune
system in vertebrate populations. Here, we have
attempted to highlight the importance of ecological and
epidemiological processes in shaping the selection pres-
sures for acquired immune memory. Future work should
look to incorporate more of the known genetic and
molecular features of the adaptive immune system, in
particular specificity, in to this evolutionary ecology
framework to gain an integrated picture of the evolution
of the adaptive immune system.
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